Dr. Glen Gaughan has almost 20 years of experience as a drug discovery scientist with Bristol-Myers Squibb. In roles ranging from Principal Investigator to Group Leader, he contributed to programs searching for new medications for pain, obesity, sleep disorders, and depression, and for contrast agents for MRI. Gaughan designed ProHance, an MRI contrast agent marketed by Bracco.
Dr. Gaughan holds a Ph.D. in Chemistry from the University of Oregon, an M.B.A from Case Western Reserve, and a B.A. from Dartmouth.